The direct effects of the released cytokines on the leukemia cells remain to be elucidated but IFN-γ definitely seems to contribute to the efficiency of cancer immunotherapy with immune checkpoint inhibitors in solid tumors [22, 23]. The gene discussed is IFNG; the disease is cancer.